Nektar Therapeutics NKTR
NASDAQ NKTR
$59.29 -1.11 (-1.84%)
As of: Sep 29, 2026 · 3:59 PM EDT

Nektar Therapeutics (NKTR) Restructuring Costs (2022 - 2026)

Updated

Nektar Therapeutics' Restructuring Costs was $578,000 in Q2 2026, up 29.3% from $447,000 a year earlier but down 27.4% from the prior quarter.

Analysis

Nektar Therapeutics (NKTR) Restructuring Costs (2022 - 2026) Analysis & Trends

On a trailing twelve-month basis, Nektar Therapeutics' Restructuring Costs was $10.09 million through Jun 30, 2026, up 399.0% year-over-year; for FY2025, it was $9.33 million, down 40.5% from FY2024.

  • Restructuring Costs has now declined for three consecutive years, with a three-year compound annual growth rate of -59.1% (FY2022 to FY2025).
  • In earlier years, Restructuring Costs was $15.67 million in FY2024 (-69.8%), $51.96 million in FY2023 (-61.8%) and $135.93 million in FY2022.
  • Quarterly Restructuring Costs has moved between $46,000 (Q3 2024) and $106.05 million (Q2 2022) over five years.
  • Compared with a year earlier, Restructuring Costs has increased for four straight quarters, with growth averaging 100.5% over the last eight quarters.
  • The best year-over-year quarter for Restructuring Costs over five years was Q4 2025 (growth of 530.5%); the worst was Q3 2024 (a decline of 99.6%).
  • Per Business Quant data, NKTR's Restructuring Costs in the three quarters before Q2 2026 was $796,000 (Q1 2026), $8.58 million (Q4 2025) and $140,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn
10 Nektar Therapeutics 2.00 Bn 227.61 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 578,000.00
Mar 31, 2026 796,000.00
Dec 31, 2025 8.58 Mn
Sep 30, 2025 140,000.00
Jun 30, 2025 447,000.00
Mar 31, 2025 169,000.00
Dec 31, 2024 1.36 Mn
Sep 30, 2024 46,000.00
Jun 30, 2024 13.29 Mn
Mar 31, 2024 975,000.00
Dec 31, 2023 2.85 Mn
Sep 30, 2023 11.36 Mn
Jun 30, 2023 16.55 Mn
Mar 31, 2023 21.19 Mn
Dec 31, 2022 11.58 Mn
Sep 30, 2022 16.83 Mn
Jun 30, 2022 106.05 Mn
Mar 31, 2022 1.48 Mn
API Access

Nektar Therapeutics Restructuring Costs API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=restructuring-costs&ticker=NKTR&period=max&api_key=YOUR_API_KEY